OMALIZUMAB-IGEC

OMALIZUMAB-IGEC was reported 89 times

These side effects are most commonly reported by patients taking OMALIZUMAB-IGEC:

# Side effect Count
0 URTICARIA 20
1 ANGIOEDEMA 16
2 PRURITUS 16
3 DYSPNOEA 15
4 MALAISE 15
5 ASTHMA 14
6 PRODUCT SUBSTITUTION ISSUE 13
7 VOMITING 13
8 COUGH 12
9 HEADACHE 12
10 PNEUMONIA 12
11 WHEEZING 12
12 ARTHRALGIA 10
13 CHEST PAIN 10
14 DIZZINESS 10
15 DRUG HYPERSENSITIVITY 10
16 RESPIRATORY TRACT INFECTION 10
17 SUSPECTED OFF LABEL USE 10
18 NASAL OEDEMA 9
19 NAUSEA 9
20 OEDEMA 9
21 PAIN 9
22 DRUG INEFFECTIVE 8
23 ASTHENIA 7
24 FATIGUE 7
25 CONDITION AGGRAVATED 6
26 ERYTHEMA 6
27 OFF LABEL USE 5
28 PALPITATIONS 5
29 ANAPHYLACTIC REACTION 4
30 BURNING SENSATION 4
31 CHEST DISCOMFORT 4
32 CHRONIC SPONTANEOUS URTICARIA 4
33 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4
34 RASH 4
35 ANXIETY 3
36 DECREASED APPETITE 3
37 GASTROOESOPHAGEAL REFLUX DISEASE 3
38 HYPERSENSITIVITY 3
39 HYPOAESTHESIA ORAL 3
40 HYPOTENSION 3
41 INFLUENZA LIKE ILLNESS 3
42 INSOMNIA 3
43 INTENTIONAL DOSE OMISSION 3
44 MIGRAINE 3
45 MYALGIA 3
46 NASOPHARYNGITIS 3
47 OVERDOSE 3
48 PAIN IN EXTREMITY 3
49 PHARYNGEAL SWELLING 3
50 SWELLING FACE 3
51 URINARY TRACT INFECTION 3
52 ABDOMINAL PAIN 2
53 ABDOMINAL PAIN UPPER 2
54 BACK PAIN 2
55 BLINDNESS 2
56 BLOOD PRESSURE SYSTOLIC INCREASED 2
57 CARPAL TUNNEL SYNDROME 2
58 CONFUSIONAL STATE 2
59 CONTUSION 2
60 DIARRHOEA 2
61 DYSPHONIA 2
62 EPISTAXIS 2
63 FACE OEDEMA 2
64 HALLUCINATION 2
65 ILLNESS 2
66 INFLAMMATION 2
67 INTENTIONAL PRODUCT USE ISSUE 2
68 LIP SWELLING 2
69 LOWER RESPIRATORY TRACT INFECTION 2
70 MYDRIASIS 2
71 OROPHARYNGEAL PAIN 2
72 PARAESTHESIA 2
73 PERIPHERAL SWELLING 2
74 PHARYNGITIS 2
75 PRESYNCOPE 2
76 PRODUCT DOSE OMISSION ISSUE 2
77 PUPILLARY REFLEX IMPAIRED 2
78 RECTAL HAEMORRHAGE 2
79 SKIN EXFOLIATION 2
80 STRESS 2
81 SUICIDAL IDEATION 2
82 SWELLING 2
83 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2
84 TINNITUS 2
85 TOOTH RESTORATION 2
86 URTICARIA CHRONIC 2
87 VISION BLURRED 2
88 WEIGHT INCREASED 2
89 ABDOMINAL DISCOMFORT 1
90 ADMINISTRATION SITE PRURITUS 1
91 ALTERED STATE OF CONSCIOUSNESS 1
92 ANAPHYLACTIC SHOCK 1
93 ANAPHYLACTOID REACTION 1
94 ANGINA PECTORIS 1
95 ARTHRITIS 1
96 ASTHMATIC CRISIS 1
97 BLADDER NEOPLASM 1
98 BLOOD IRON DECREASED 1
99 BODY TEMPERATURE ABNORMAL 1
100 BORDERLINE PERSONALITY DISORDER 1
101 BREAST CANCER 1
102 BRONCHOSPASM 1
103 CALCINOSIS 1
104 CHOKING 1
105 CIRCADIAN RHYTHM SLEEP DISORDER 1
106 CONCOMITANT DISEASE AGGRAVATED 1
107 CONCUSSION 1
108 CONJUNCTIVAL HYPERAEMIA 1
109 CONJUNCTIVAL OEDEMA 1
110 CONJUNCTIVITIS 1
111 CONTRAINDICATED PRODUCT ADMINISTERED 1
112 CROHN^S DISEASE 1
113 CYCLIC VOMITING SYNDROME 1
114 DEEP VEIN THROMBOSIS 1
115 DERMATITIS EXFOLIATIVE 1
116 DISEASE RECURRENCE 1
117 DRUG EFFECT LESS THAN EXPECTED 1
118 DRY SKIN 1
119 DYSGEUSIA 1
120 DYSPEPSIA 1
121 ECZEMA 1
122 EHLERS-DANLOS SYNDROME 1
123 EMOTIONAL DISTRESS 1
124 ENLARGED UVULA 1
125 EXERCISE TOLERANCE DECREASED 1
126 EXFOLIATIVE RASH 1
127 EYE IRRITATION 1
128 EYE PRURITUS 1
129 EYELID OEDEMA 1
130 FALL 1
131 FEELING ABNORMAL 1
132 FLUID RETENTION 1
133 FLUSHING 1
134 GENERAL PHYSICAL HEALTH DETERIORATION 1
135 GENERALISED TONIC-CLONIC SEIZURE 1
136 HAEMORRHAGE URINARY TRACT 1
137 HAIR DISORDER 1
138 HARVEY-BRADSHAW INDEX INCREASED 1
139 HEART RATE INCREASED 1
140 HEPATITIS 1
141 HEREDITARY ANGIOEDEMA 1
142 HERPES ZOSTER 1
143 HIP FRACTURE 1
144 HOT FLUSH 1
145 HYPOKALAEMIA 1
146 IMPAIRED DRIVING ABILITY 1
147 INCORRECT DOSE ADMINISTERED 1
148 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1
149 INFECTION 1
150 INFLUENZA 1
151 INJECTION RELATED REACTION 1
152 INJECTION SITE BRUISING 1
153 INJECTION SITE HYPERSENSITIVITY 1
154 INJECTION SITE INFLAMMATION 1
155 INJECTION SITE PAIN 1
156 INJECTION SITE PLAQUE 1
157 IRON DEFICIENCY 1
158 KNEE ARTHROPLASTY 1
159 LETHARGY 1
160 LOCALISED OEDEMA 1
161 LOWER RESPIRATORY TRACT INFECTION VIRAL 1
162 MAST CELL ACTIVATION SYNDROME 1
163 MIDDLE INSOMNIA 1
164 MOUTH ULCERATION 1
165 MUSCLE SPASMS 1
166 NEPHROLITHIASIS 1
167 ODYNOPHAGIA 1
168 ORAL HERPES 1
169 OVARIAN CYST 1
170 OVERLAP SYNDROME 1
171 PALLOR 1
172 PARAESTHESIA ORAL 1
173 PELVIC PAIN 1
174 PHARYNGEAL OEDEMA 1
175 PHOTOSENSITIVITY REACTION 1
176 PLATELET COUNT DECREASED 1
177 POLYARTHRITIS 1
178 PRODUCT AVAILABILITY ISSUE 1
179 PRODUCT SUPPLY ISSUE 1
180 PRODUCT USE ISSUE 1
181 PYREXIA 1
182 RASH ERYTHEMATOUS 1
183 RASH MACULAR 1
184 RASH MACULO-PAPULAR 1
185 RESPIRATORY DISORDER 1
186 RETCHING 1
187 RHEUMATOID ARTHRITIS 1
188 RHINITIS 1
189 ROAD TRAFFIC ACCIDENT 1
190 SCRATCH 1
191 SEIZURE 1
192 SENSITIVE SKIN 1
193 SINUS PAIN 1
194 SINUSITIS 1
195 SKIN BURNING SENSATION 1
196 SKIN LESION 1
197 SKIN MASS 1
198 SKIN PLAQUE 1
199 SLEEP APNOEA SYNDROME 1
200 SLEEP DISORDER 1
201 SOMNOLENCE 1
202 SPEECH DISORDER 1
203 SUNBURN 1
204 SWOLLEN TONGUE 1
205 SYMPTOM RECURRENCE 1
206 SYNCOPE 1
207 TACHYCARDIA 1
208 THERAPEUTIC RESPONSE CHANGED 1
209 THERAPY INTERRUPTED 1
210 THROAT IRRITATION 1
211 THROAT TIGHTNESS 1
212 THROMBOCYTOPENIA 1
213 TREMOR 1
214 UNDERDOSE 1
215 UNEVALUABLE EVENT 1
216 UNRESPONSIVE TO STIMULI 1
217 URETHRAL NEOPLASM 1
218 URTICARIAL VASCULITIS 1